Prescription-drug middlemen face mounting pressure from federal government, states

日本 ニュース ニュース

Prescription-drug middlemen face mounting pressure from federal government, states
日本 最新ニュース,日本 見出し
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 76 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 34%
  • Publisher: 97%

‘Heat wave’ for pharmacy benefit managers as lawmakers, regulators scrutinize impact on drug prices

Political and legal troubles are piling up around the companies that act as influential middlemen in the U.S. prescription-drug system.

And in a Congress that has few points of bipartisan agreement, lawmakers on both sides of the aisle have shown interest in investigating or restricting some PBM practices. The Senate Commerce Committee last week approved a bill that would prohibit certain PBM pricing practices and require the companies to disclose more information on how they’re paying pharmacies for drugs, among other details.

Central players who influence drug cost and access As central players negotiating with drugmakers and pharmacies, PBMs can influence which drugs are prescribed to patients, patient access to medications, payment terms for pharmacies, total drug costs for insurers and how much patients ultimately pay for their drugs, researchers and regulators say.

PBMs say they play a critical role in securing drug savings, supporting patients’ access to prescriptions and promoting better health outcomes. The Pharmaceutical Care Management Association, a PBM trade group, said in February that it was launching a seven-figure advertising campaign to highlight “the irreplaceable value of America’s pharmacy benefit companies” and promote ideas to increase competition as the best way to address high drug prices.

The high sticker price matters, Feldman said in her testimony, in part because in many insurance plans the patient’s out-of-pocket cost is calculated as a percentage of that sticker price. It also matters to the many Americans who don’t have prescription-drug coverage, she said.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

MarketWatch /  🏆 3. in US

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Uber Health expands same-day prescription drug deliveryUber Health expands same-day prescription drug deliveryUber Health wants to have prescriptions dropped off the same day at patients' homes.
続きを読む »

Monarch eTNS: Non-Medication Prescription Device for ADHDMonarch eTNS: Non-Medication Prescription Device for ADHDThe Monarch eTNS device is a digital therapy for children with ADHD ages 7 to 12 that sends low stimulating pulses to the trigeminal nerve through a disposable patch placed on a child’s forehead at bedtime.
続きを読む »

FDA approves over-the-counter sales of NarcanFDA approves over-the-counter sales of NarcanThe U.S. Food and Drug Administration on Wednesday approved selling naloxone without a prescription
続きを読む »

Google Adds Extreme Heat Warnings and Other Climate ToolsGoogle Adds Extreme Heat Warnings and Other Climate ToolsThe tech behemoth will now offer more location-specific info on heatwaves in its search engine results, along with new climate tools for city planners.
続きを読む »

Google is adding extreme heat alerts to search to combat climate changeGoogle is adding extreme heat alerts to search to combat climate changeGoogle wants to help combat climate change by informing people of extreme heat in their area when they search.
続きを読む »

Google search adds hyperlocal extreme-heat warnings to its flood and wildfire alertsGoogle search adds hyperlocal extreme-heat warnings to its flood and wildfire alerts'Climate change is the defining challenge of our generation,' Google says as it announces adding heat warnings to flood and wildfire alerts within its search.
続きを読む »



Render Time: 2025-02-28 20:34:24